2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Alexandros Protonotarios et al.|European Heart Journal|2023Cited by 2.3k
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trialMarc S. Sabatine, Terje R. Pedersen, Yehuda Handelsman et al.|The Lancet Diabetes & Endocrinology|2017Cited by 595
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy RegistryLia Crotti, Peter J. Schwartz, Carla Spazzolini et al.|European Heart Journal|2019Cited by 184
Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath toolAlessandro Sionís, José Luis Zamorano, Alberico L. Catapano et al.|Atherosclerosis Supplements|2020Cited by 14
Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter StudyPaolo Compagnucci, Michela Casella, Antonio Dello Russo et al.|Journal of Clinical Medicine|2022Cited by 10